Literature DB >> 15645696

Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity.

Przemyslaw J Tomasik1, Krystyna Sztefko, Jerzy Starzyk.   

Abstract

Cholecystokinin (CCK), glucose dependent insulinotropic peptide (GIP), and glucagon-like peptide 1 (GLP-1) regulate satiety as enterogastrons and incretins. They also directly affect the satiety centers. Therefore, these peptides may participate in the pathogenesis of eating disorders. CCK, GIP, and GLP-1 secretion were studied in 13 adolescent girls suffering from simple obesity, 13 girls with anorexia nervosa, and 10 healthy girls. Each girl was subjected to an oral glucose tolerance test (OGTT) and standard meal test. Blood was collected before stimulation and at 15, 30, 60, and 120 min. The concentrations of all peptides were determined by RIA commercial kits. Fasting and postprandial levels of these peptides as well as integrated outputs were measured. High postprandial levels of CCK observed in the girls with anorexia may aggravate the course of this disease by intensifying nausea and vomiting. Low postprandial level of GLP-1 in girls with simple obesity may be responsible for excessive ingestion of food and weaker inhibition of gastric emptying, which also leads to obesity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15645696     DOI: 10.1515/jpem.2004.17.12.1623

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  10 in total

Review 1.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

2.  Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa.

Authors:  Monica H Wojcik; Erinne Meenaghan; Elizabeth A Lawson; Madhusmita Misra; Anne Klibanski; Karen K Miller
Journal:  Bone       Date:  2009-11-18       Impact factor: 4.398

3.  Influence of sleeve gastrectomy on several experimental models of obesity: metabolic and hormonal implications.

Authors:  Fàtima Sabench Pereferrer; Mercè Hernàndez Gonzàlez; Albert Feliu Rovira; Santiago Blanco Blasco; Antonio Morandeira Rivas; Daniel del Castillo Déjardin
Journal:  Obes Surg       Date:  2007-12-08       Impact factor: 4.129

4.  Severe hypoglycemia in a patient with anorexia nervosa.

Authors:  H Yanai; H Yoshida; Y Tomono; N Tada
Journal:  Eat Weight Disord       Date:  2008-03       Impact factor: 4.652

5.  Ghrelin: central and peripheral implications in anorexia nervosa.

Authors:  Mathieu Méquinion; Fanny Langlet; Sara Zgheib; Suzanne Dickson; Bénédicte Dehouck; Christophe Chauveau; Odile Viltart
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-26       Impact factor: 5.555

6.  The effect of family-based multidisciplinary cognitive behavioral treatment in children with obesity: study protocol for a randomized controlled trial.

Authors:  Rimke C Vos; Jan M Wit; Hanno Pijl; Carolien C Kruyff; Euphemia C A M Houdijk
Journal:  Trials       Date:  2011-05-06       Impact factor: 2.279

7.  The effect of multidisciplinary lifestyle intervention on the pre- and postprandial plasma gut Peptide concentrations in children with obesity.

Authors:  Rimke C Vos; Hanno Pijl; Jan M Wit; Erik W van Zwet; Chris van der Bent; Euphemia C A M Houdijk
Journal:  ISRN Endocrinol       Date:  2011-06-01

Review 8.  MECHANISMS IN ENDOCRINOLOGY: Anorexia nervosa and endocrinology: a clinical update.

Authors:  René Klinkby Støving
Journal:  Eur J Endocrinol       Date:  2019-01-01       Impact factor: 6.664

9.  Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa.

Authors:  Ulrich Cuntz; Paul Enck; Erich Frühauf; Peter Lehnert; Rudolf L Riepl; Manfred M Fichter; Bärbel Otto
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

10.  Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons.

Authors:  Xiaosong Ma; Jens Bruning; Frances M Ashcroft
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.709

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.